Association of immunoglobulin E levels with glioma risk and survival
JNCI: Journal of the National Cancer Institute · 01.03.2025 · 117 (3) · 545-553
DOI: 10.1093/jnci/djae265 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 24.10.2024. Verfasst von Geno Guerra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Glioma, Immunoglobulin E, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Brain Tumor Foundation, NCRR NIH HHS.
Abstract (Originalsprache)
Background
Previous epidemiological studies have reported an association of serum immunoglobulin E (IgE) levels with reduced glioma risk, but the association between IgE and glioma prognosis has not been characterized. This study aimed to examine how sex, tumor subtype, and IgE class modulate the association of serum IgE levels with glioma risk and survival.
Methods
We conducted a case-control study using participants from the University of California San Francisco Adult Glioma Study (1997-2010). Serum IgE levels for total, respiratory, and food allergy were measured in adults diagnosed with glioma (n = 1319) and cancer-free control individuals (n = 1139) matched based on age, sex, and race and ethnicity. Logistic regression was adjusted for patient demographics to assess the association between IgE levels and glioma risk. Multivariable Cox regression adjusted for patient-specific and tumor-specific factors compared survival between the elevated and normal IgE groups. All statistical tests were 2-sided.
Results
Elevated total IgE was associated with reduced risk of IDH wild-type glioma (risk ratio [RR] = 0.78, 95% CI = 0.71 to 0.86) and IDH-mutant glioma (RR = 0.73, 95% CI = 0.63 to 0.85). In multivariable Cox regression, positive respiratory IgE was associated with improved survival for IDH wild-type glioma (RR = 0.79, 95% CI = 0.67 to 0.93). The reduction in mortality risk was statistically significant in female individuals only (RR = 0.75, 95% CI = 0.57 to 0.98), with an improvement in median survival of 6.9 months (P < .001).
Conclusion
Elevated serum IgE was associated with improved prognosis for IDH wild-type glioma, with a more pronounced protective effect in female than male individuals, which has implications for the future study of IgE-based immunotherapies for glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States.
- Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, United States.
- Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States.
- Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
- Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, United States.
- Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, United States.
ORCID-Profile: Geno Guerra, Taishi Nakase, Linda Kachuri, Lucie McCoy, Joseph L Wiemels, Annette M Molinaro, Stephen S Francis
Förderung
- NCI NIH HHS
- National Brain Tumor Foundation
- NCRR NIH HHS
- NIH HHS
- Stanford University
- Robert Magnin Newman Endowed Chair in Neuro-Oncology
- University of California San Francisco
- NCATS NIH HHS
Zitieren
APA
Guerra, G., Nakase, T., Kachuri, L., McCoy, L., Hansen, H. M., Rice, T., Wiemels, J. L., Wiencke, J. K., Molinaro, A. M., Wrensch, M., & Francis, S. S. (2025). Association of immunoglobulin E levels with glioma risk and survival. JNCI: Journal of the National Cancer Institute, 117(3), 545-553. https://doi.org/10.1093/jnci/djae265
Vancouver
Guerra G, Nakase T, Kachuri L, McCoy L, Hansen HM, Rice T, et al. Association of immunoglobulin E levels with glioma risk and survival. JNCI: Journal of the National Cancer Institute. 2025;117(3):545-553. doi:10.1093/jnci/djae265
BibTeX
@article{Guerra2025,
author = {Guerra, Geno and Nakase, Taishi and Kachuri, Linda and McCoy, Lucie and Hansen, Helen M and Rice, Terri and Wiemels, Joseph L and Wiencke, John K and Molinaro, Annette M and Wrensch, Margaret and Francis, Stephen S},
title = {Association of immunoglobulin E levels with glioma risk and survival},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
volume = {117},
number = {3},
pages = {545--553},
doi = {10.1093/jnci/djae265}
}
EUVIMED